Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Arcturus Therapeutics Holdings Inc., 3 years.
Arcturus Therapeutics Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Scholar Rock Holding Corporation | Open-market sale | −4,157 | $46.53 | $193,425 |
| Feb 9, 2026 | Scholar Rock Holding Corporation | Grant or award | +34,482 | — | — |
| Jan 16, 2026 | Scholar Rock Holding Corporation | Open-market sale | −5,798 | $44.48 | $257,895 |
| Mar 10, 2025 | Scholar Rock Holding Corporation | Grant or award | +34,285 | — | — |
| Jan 16, 2025 | Scholar Rock Holding Corporation | Open-market sale | −5,655 | $44.20 | $249,951 |
| Nov 25, 2024 | Scholar Rock Holding Corporation | Option exercise | +6,375 | $8.59 | $54,761 |
| Nov 25, 2024 | Scholar Rock Holding Corporation | Open-market sale | −1,000 | $38.04 | $38,040 |
| Nov 25, 2024 | Scholar Rock Holding Corporation | Open-market sale | −2,100 | $39.25 | $82,425 |
| Nov 25, 2024 | Scholar Rock Holding Corporation | Open-market sale | −3,075 | $39.93 | $122,785 |
| Nov 25, 2024 | Scholar Rock Holding Corporation | Open-market sale | −200 | $40.72 | $8,144 |
| Nov 22, 2024 | Scholar Rock Holding Corporation | Option exercise | +2,145 | $8.59 | $18,426 |
| Nov 22, 2024 | Scholar Rock Holding Corporation | Open-market sale | −2,145 | $30.01 | $64,371 |
| Nov 11, 2024 | Scholar Rock Holding Corporation | Option exercise | +2,105 | $8.59 | $18,082 |
| Nov 11, 2024 | Scholar Rock Holding Corporation | Open-market sale | −2,105 | $30.00 | $63,150 |
| Oct 7, 2024 | Scholar Rock Holding Corporation | Option exercise | +109,375 | $8.59 | $939,531 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.